Asan Multivessel Registry (ASAN MV)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02039752
Recruitment Status : Recruiting
First Posted : January 20, 2014
Last Update Posted : March 5, 2018
CardioVascular Research Foundation, Korea
Information provided by (Responsible Party):
Seung-Jung Park, Asan Medical Center

Brief Summary:
The purpose of this study is to evaluate long-term prognoses of patients with multivessel coronary disease treated medically or surgically or percutaneously in real world practice.

Condition or disease Intervention/treatment
Coronary Artery Disease Other: Treatment

Study Type : Observational
Estimated Enrollment : 25000 participants
Observational Model: Cohort
Time Perspective: Other
Official Title: Asan Medical Center Registry for Multivessel
Actual Study Start Date : March 2014
Estimated Primary Completion Date : June 2030
Estimated Study Completion Date : December 2030

Group/Cohort Intervention/treatment
from 1995
Other: Treatment
Other Names:
  • Medically
  • Surgically
  • Percutaneously

Primary Outcome Measures :
  1. composite event [ Time Frame: 1year ]
    death, myocardial infarction, stroke, revascularization

Secondary Outcome Measures :
  1. Death [ Time Frame: 1year ]
  2. Myocardial Infarction [ Time Frame: 1year ]
  3. Stroke [ Time Frame: 1year ]
  4. Revascularization [ Time Frame: 1year ]
  5. Angina symptom [ Time Frame: 1year ]
  6. Bleeding [ Time Frame: 1year ]
  7. Re-hospitalization [ Time Frame: 1year ]
  8. Stent thrombosis [ Time Frame: 1year ]
    by ARC(Academic Research Consortium) category

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   19 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with multivessel disease from 1995 in Asan Medical Center

Inclusion Criteria:

  • Patients with multivessel disease from 1995 in Asan Medical Center
  • Age 19 and more

Exclusion Criteria:

  • For prospective cohort, not agreeing to participate with written informed consent form

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02039752

Korea, Republic of
Asan Medical Center Recruiting
Seoul, Korea, Republic of
Contact: Seung-Jung Park, MD,PhD   
Contact: Jung-Hee Ham   
Principal Investigator: Seung-Jung Park, MD,PhD         
Sponsors and Collaborators
Seung-Jung Park
CardioVascular Research Foundation, Korea

Responsible Party: Seung-Jung Park, MD,PhD, Asan Medical Center Identifier: NCT02039752     History of Changes
Other Study ID Numbers: AMCCV2013-15
First Posted: January 20, 2014    Key Record Dates
Last Update Posted: March 5, 2018
Last Verified: March 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Keywords provided by Seung-Jung Park, Asan Medical Center:

Additional relevant MeSH terms:
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Heart Diseases
Cardiovascular Diseases
Arterial Occlusive Diseases
Vascular Diseases